PRVA Stock Analysis: Buy, Sell, or Hold?
PRVA - Privia Health Group, Inc. Common Stock
$27.36
0.48 (1.79%)
▲
5d:
+11.54%
30d:
+31.54%
90d:
+29.85%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: PRVA is 14.2% above its trading range ($23.95). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: PRVA is 14.2% above its trading range ($23.95). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.98
Based on 9.6% avg growth
INTRINSIC VALUE TODAY
$22.34
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $27.36, which is considered extended relative to its 30-day fair value range of $21.56 to $23.95. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.9) compared to its historical average (20.8). At these levels, the market is pricing in 6.2% annual earnings growth.
Technical Outlook: Technically, PRVA is showing sideways momentum. The price is approaching resistance at $22.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.42 (+14.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRVA is showing sideways momentum. The price is approaching resistance at $22.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.42 (+14.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.56 -
$23.95
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
Protect Your Profits
PRVA is technically overbought (RSI 81). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.2% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($31.42)
- BULLISH: Expecting earnings turnaround to 6.2% growth with 25.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$21.56 -
$23.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.48
Resistance Level
$22.51
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.93
Wall Street Target
$31.42
(+14.8%)
Revenue Growth (YoY)
25.8%
Earnings Growth (YoY)
-33.3%
Profit Margin
1.0%
Valuation Premium vs History
+6.2% premium
PE vs Historical
24.9 vs 20.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.2%
(market-implied from PE analysis)
1-Year Target
$29.06
(+6%)
2-Year Target
$30.86
(+13%)
3-Year Target
$32.77
(+20%)
3-Yr Target (if PE normalizes)
(PE: 25→21)
PE COMPRESSION
$27.34
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.9, Growth: 15.2%)
$41.88
(+53%)
Base:
(SPY PE: 21.8, Growth: 15.2%)
$36.59
(+34%)
Bear:
(PE: 18.5, Growth: 15.2%)
$31.10
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Forward PE: 29.50 | Forward EPS (Implied): $0.93
Bull Case
$33.04
(+21%)
Analyst growth 15.0%, PE expands to 31.0
Base Case
$27.36
(0%)
Market implied 0.0%, PE stable at 29.5
Bear Case
$20.93
(-24%)
Severe decline -15.0%, PE contracts to 26.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 4:34 PM ET
Data refreshes hourly during market hours. Next update: 5:34 PM
Data refreshes hourly during market hours. Next update: 5:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
David Mountcastle
SELL
5566 shares
2026-04-02
David Mountcastle
SELL
6391 shares
2026-03-16
Parth Mehrotra
SELL
26509 shares
2026-03-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 54 HOLD |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
